- 2mg
2mg
Pack of 50 Tablets | $ 90 ($1.80 / Unit) | Add To Cart |
Pack of 100 Tablets | $ 170 ($1.70 / Unit) | Add To Cart |
Pack of 200 Tablets | $ 310 ($1.55 / Unit) | Add To Cart |
Pack of 300 tablets | $ 420 ($1.40 / Unit) | Add To Cart |
Pack of 500 Tablets | $ 490 ($0.98 / Unit) | Add To Cart |
About Of Zunestar 2 Mg
- Zunestar 2 mg is a medication that contains Zolpidem, which is primarily used as a short-term treatment for insomnia.
- Zolpidem belongs to a class of drugs known as sedative-hypnotics, which work by slowing down brain activity to help with falling asleep.
Common Uses
- Insomnia: Zunestar 2 mg is prescribed to help with difficulties falling asleep or staying asleep, which are common symptoms of insomnia. It helps patients achieve a better quality of sleep, typically for short periods (usually 7-10 days).
How It Works
Zunestar 2 mg tablet works by enhancing the effects of gamma-aminobutyric acid (GABA), a neurotransmitter in the brain that induces relaxation and sleep. By increasing GABA activity, Zolpidem helps calm the central nervous system, making it easier to fall asleep.
Dosage
- The typical dose for adults is 2 mg taken immediately before bedtime. The dose may be adjusted based on the patient’s age, medical condition, and response to treatment. So you are recommended to use the lowest effective dose.
- Take Zunestar 2 mg pills on an empty stomach, as food can delay the onset of its effects.
- Drink a glass of water and swallow the tablet whole without crushing or chewing it.
- You should take the medication only when you have time for a full night’s rest (7-8 hours).
- Do not take Zunestar 2 mg if you cannot stay in bed for a full night, as it may cause drowsiness or memory issues the next day.
Active Ingredient (Generic Name): | Eszopiclone |
---|---|
Manufacturer: | HAB Pharmaceuticals & Research Ltd |
Packaging | 10 Tablets in a strip |
Strength: | 2mg |
Delivery Time: | 6 To 15 days |
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.